Eli Lilly (LLY)
(Delayed Data from NYSE)
$952.74 USD
-1.43 (-0.15%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $950.50 -2.24 (-0.24%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Earnings News For LLY
-
Eli Lilly (LLY) Q2 Earnings Top, Mounjaro, Zepbound Drive View
-
Lilly: Q2 Earnings Snapshot
-
Eli Lilly (LLY) Surpasses Q2 Earnings and Revenue Estimates
-
Can Mounjaro & Zepbound Drive Eli Lilly (LLY) Q2 Earnings?
-
Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?
-
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
-
Eli Lilly (LLY) Tops Q1 Earnings Estimates
-
Lilly: Q1 Earnings Snapshot
-
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
-
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
-
Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue?
-
Eli Lilly (LLY) Q4 Earnings Beat, Mounjaro, Zepbound Drive Sales
-
Eli Lilly (LLY) Tops Q4 Earnings and Revenue Estimates
-
Lilly: Q4 Earnings Snapshot
-
Lilly: Q4 Earnings Snapshot
-
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance
-
Eli Lilly (LLY) to Report Q4 Earnings: What's in the Cards?
-
Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?
-
Eli Lilly (LLY) Q3 Earnings & Sales Top, EPS View Cut, Stock Up
-
Lilly: Q3 Earnings Snapshot
-
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity
-
Earnings Preview: Eli Lilly (LLY) Q3 Earnings Expected to Decline
-
Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards?
-
Why Is Lilly (LLY) Up 6.4% Since Last Earnings Report?